Asymptomatic Peripheral Arterial Disease Among Jordanian Patients With Diabetic Foot Ulcer
- PMID: 39677274
- PMCID: PMC11646323
- DOI: 10.7759/cureus.73722
Asymptomatic Peripheral Arterial Disease Among Jordanian Patients With Diabetic Foot Ulcer
Abstract
Background and objective Peripheral arterial disease (PAD) is a common disorder that is usually associated with leg symptoms such as intermittent claudication (IC), which could be masked by peripheral neuropathy in diabetic patients. In this study, we aimed to assess the prevalence and associated risk factors of asymptomatic PAD among Jordanian patients with diabetic foot ulcers. Methods A cross-sectional study involving diabetic foot patients attending the diabetic foot clinic at the Medical City in Royal Medical Services in Amman, Jordan, was conducted from January 2023 to March 2024. The criteria for the diagnosis of asymptomatic PAD were as follows: patients with toe brachial index (TBI) <0.7 and no leg symptoms as determined by the San Diego Claudication Questionnaire (SDCQ). Results PAD was observed in 38 out of 133 patients (28.6%). Of these, 26 patients (68.4%) had asymptomatic PAD. Statistically significant associations were observed between PAD and male gender, former smoking, cerebrovascular disease (CVD), age, duration of diabetes, and high-density lipoprotein (HDL). Multiple binary logistic regression showed that ex-smoking and age had a significant impact on developing PAD; ex-smoker patients were 4.75 times [95% confidence interval (CI): 1.26-17.90, p=0.021] more likely to have PAD than non-smokers, and the odds ratio (OR) of having PAD increased by 1.05 times for each additional year of patient age (95% CI: 1.004-1.095, p=0.032). In investigating factors associated with asymptomatic PAD, only hypertension showed significant results. Conclusions The prevalence of asymptomatic PAD is relatively high in diabetic foot patients. PAD may delay wound healing and lead to limp loss and poorer quality of life.
Keywords: asymptomatic; claudication; diabetes mellitus; peripheral arterial disease; toe brachial index.
Copyright © 2024, Abu-Jableh et al.
Conflict of interest statement
Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. Jordanian Royal Medical Services Ethical committee issued approval 29. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Similar articles
-
Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis.Ont Health Technol Assess Ser. 2010;10(18):1-88. Epub 2010 Sep 1. Ont Health Technol Assess Ser. 2010. PMID: 23074395 Free PMC article.
-
[Recurrence and influencing factors of diabetic foot ulcer in patients with type 2 diabetes mellitus].Zhonghua Shao Shang Za Zhi. 2020 Oct 20;36(10):947-952. doi: 10.3760/cma.j.cn501120-20190726-00315. Zhonghua Shao Shang Za Zhi. 2020. PMID: 33105947 Chinese.
-
Noninvasive Arterial Testing in Patients With Diabetes: A Guide for Foot and Ankle Surgeons.Foot Ankle Int. 2015 Dec;36(12):1391-9. doi: 10.1177/1071100715593888. Epub 2015 Jul 20. Foot Ankle Int. 2015. PMID: 26194106
-
Toe-brachial index and toe systolic blood pressure for the diagnosis of peripheral arterial disease.Cochrane Database Syst Rev. 2024 Oct 30;10(10):CD013783. doi: 10.1002/14651858.CD013783.pub2. Cochrane Database Syst Rev. 2024. PMID: 39474992 Free PMC article.
-
Contemporary Medical Management of Peripheral Arterial Disease.Cardiovasc Drugs Ther. 2025 Apr;39(2):357-371. doi: 10.1007/s10557-023-07516-2. Epub 2023 Nov 2. Cardiovasc Drugs Ther. 2025. PMID: 37914901 Review.
References
-
- Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Fowkes FG, Rudan D, Rudan I, et al. Lancet. 2013;382:1329–1340. - PubMed
-
- Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Saeedi P, Petersohn I, Salpea P, et al. Diabetes Res Clin Pract. 2019;157:107843. - PubMed
-
- Epidemiology of peripheral artery disease. Criqui MH, Aboyans V. Circ Res. 2015;116:1509–1526. - PubMed
LinkOut - more resources
Full Text Sources